메뉴 건너뛰기




Volumn 18, Issue 7-8, 2013, Pages 389-398

Quinolines: A new hope against inflammation

Author keywords

[No Author keywords available]

Indexed keywords

BMS 561392; CYTOKINE; D 4418; GSK 256066; N (3,5 DICHLORO 1 OXIDO 4 PYRIDINYL) 8 METHOXY 2 TRIFLUOROMETHYL 5 QUINOLINECARBOXAMIDE; PHOSPHODIESTERASE IV; PROSTAGLANDIN; PROSTAGLANDIN INHIBITOR; PROSTAGLANDIN SYNTHASE; QUINOLINE DERIVED ANTIINFECTIVE AGENT; ROLIPRAM; SCH 365351; TUMOR NECROSIS FACTOR ALPHA; TUMOR NECROSIS FACTOR ALPHA CONVERTING ENZYME; UNCLASSIFIED DRUG; VANILLOID RECEPTOR 1 ANTAGONIST;

EID: 84875728346     PISSN: 13596446     EISSN: 18785832     Source Type: Journal    
DOI: 10.1016/j.drudis.2012.11.003     Document Type: Review
Times cited : (96)

References (73)
  • 2
    • 0036566639 scopus 로고    scopus 로고
    • Atherosclerosis: The new view
    • P. Libby Atherosclerosis: the new view Sci. Am. 286 2002 46 55
    • (2002) Sci. Am. , vol.286 , pp. 46-55
    • Libby, P.1
  • 3
    • 33745571976 scopus 로고    scopus 로고
    • The immune response in atherosclerosis: A double-edged sword
    • DOI 10.1038/nri1882, PII N1882
    • G.K. Hansson, and P. Libby The immune response in atherosclerosis: a double-edged sword Nat. Rev. Immunol. 6 2006 508 519 (Pubitemid 43980523)
    • (2006) Nature Reviews Immunology , vol.6 , Issue.7 , pp. 508-519
    • Hansson, G.K.1    Libby, P.2
  • 4
    • 79955004745 scopus 로고    scopus 로고
    • Quinoline as a privileged scaffold in cancer drug discovery
    • V.R. Solomon, and H. Lee Quinoline as a privileged scaffold in cancer drug discovery Curr. Med. Chem. 18 2011 1488 1508
    • (2011) Curr. Med. Chem. , vol.18 , pp. 1488-1508
    • Solomon, V.R.1    Lee, H.2
  • 5
    • 0034658440 scopus 로고    scopus 로고
    • Reversal of MRP-mediated doxorubicin resistance with quinoline-based drugs
    • DOI 10.1016/S0006-2952(00)00270-7, PII S0006295200002707
    • M. Vezmar, and E. Georges Reversal of MRP-mediated doxorubicin resistance with quinoline-based drugs Biochem. Pharmacol. 59 2000 1245 1252 (Pubitemid 30157887)
    • (2000) Biochemical Pharmacology , vol.59 , Issue.10 , pp. 1245-1252
    • Vezmar, M.1    Georges, E.2
  • 6
    • 77954309291 scopus 로고    scopus 로고
    • Quinolines and structurally related heterocycles as antimalarials
    • K. Kaur Quinolines and structurally related heterocycles as antimalarials Eur. J. Med. Chem. 45 2010 3245 3264
    • (2010) Eur. J. Med. Chem. , vol.45 , pp. 3245-3264
    • Kaur, K.1
  • 7
    • 0026680407 scopus 로고
    • Quinolone antimicrobial agents
    • H.C. Neu Quinolone antimicrobial agents Annu. Rev. Med. 43 1992 465 486
    • (1992) Annu. Rev. Med. , vol.43 , pp. 465-486
    • Neu, H.C.1
  • 8
    • 0033791318 scopus 로고    scopus 로고
    • Cyclooxygenases: Structural, cellular, and molecular biology
    • W.L. Smith Cyclooxygenases: structural, cellular, and molecular biology Annu. Rev. Biochem. 69 2000 145 182
    • (2000) Annu. Rev. Biochem. , vol.69 , pp. 145-182
    • Smith, W.L.1
  • 9
    • 0033551847 scopus 로고    scopus 로고
    • Arachidonic acid oxygenation by COX-1 and COX-2. Mechanisms of catalysis and inhibition
    • L.J. Marnett Arachidonic acid oxygenation by COX-1 and COX-2. Mechanisms of catalysis and inhibition J. Biol. Chem. 274 1999 22903 22906
    • (1999) J. Biol. Chem. , vol.274 , pp. 22903-22906
    • Marnett, L.J.1
  • 10
    • 34147119080 scopus 로고    scopus 로고
    • Structural and functional basis of cyclooxygenase inhibition
    • DOI 10.1021/jm0613166
    • A.L. Blobaum, and L.J. Marnett Structural and functional basis of cyclooxygenase inhibition J. Med. Chem. 50 2007 1425 1441 (Pubitemid 46564365)
    • (2007) Journal of Medicinal Chemistry , vol.50 , Issue.7 , pp. 1425-1441
    • Blobaum, A.L.1    Marnett, L.J.2
  • 11
    • 0034926291 scopus 로고    scopus 로고
    • The vanilloid receptor: A molecular gateway to the pain pathway
    • DOI 10.1146/annurev.neuro.24.1.487
    • M.J. Caterina, and D. Julius The vanilloid receptor: a molecular gateway to the pain pathway Annu. Rev. Neurosci. 24 2001 487 517 (Pubitemid 32695237)
    • (2001) Annual Review of Neuroscience , vol.24 , pp. 487-517
    • Caterina, M.J.1    Julius, D.2
  • 14
    • 65549133355 scopus 로고    scopus 로고
    • Vanilloid receptor antagonists: Emerging class of novel anti-inflammatory agents for pain management
    • M. Pal Vanilloid receptor antagonists: emerging class of novel anti-inflammatory agents for pain management Curr. Pharm. Des. 15 2009 1008 1026
    • (2009) Curr. Pharm. Des. , vol.15 , pp. 1008-1026
    • Pal, M.1
  • 15
    • 15144351114 scopus 로고
    • Transmembrane signalling second messenger analogues and inositol phosphates
    • C. Hansch, Pergamon Press Oxford, UK
    • B.V.L. Potter Transmembrane signalling second messenger analogues and inositol phosphates C. Hansch, Comprehensive Medicinal Chemistry 1990 Pergamon Press Oxford, UK 102 128
    • (1990) Comprehensive Medicinal Chemistry , pp. 102-128
    • Potter, B.V.L.1
  • 16
    • 0031601339 scopus 로고    scopus 로고
    • The multienzyme PDE4 cyclic adenosine monophosphate-specific phosphodiesterase family: Intracellular targeting, regulation, and selective inhibition by compounds exerting anti-inflammatory and antidepressant actions
    • M.D. Houslay The multienzyme PDE4 cyclic adenosine monophosphate-specific phosphodiesterase family: intracellular targeting, regulation, and selective inhibition by compounds exerting anti-inflammatory and antidepressant actions Adv. Pharmacol. 44 1998 225 342
    • (1998) Adv. Pharmacol. , vol.44 , pp. 225-342
    • Houslay, M.D.1
  • 17
    • 21144437565 scopus 로고    scopus 로고
    • Phosphodiesterase: Overview of protein structures, potential therapeutic applications and recent progress in drug development
    • DOI 10.1007/s00018-005-4533-5
    • Y.H. Jeon Phosphodiesterase: overview of protein structures, potential therapeutic applications and recent progress in drug development Cell. Mol. Life Sci. 62 2005 1198 1220 (Pubitemid 40880125)
    • (2005) Cellular and Molecular Life Sciences , vol.62 , Issue.11 , pp. 1198-1220
    • Jeon, Y.H.1    Heo, Y.-S.2    Kim, C.M.3    Hyun, Y.-L.4    Lee, T.G.5    Ro, S.6    Cho, J.M.7
  • 18
    • 52449115420 scopus 로고    scopus 로고
    • Recent advances on phosphodiesterase 4 inhibitors for the treatment of asthma and chronic obstructive pulmonary disease
    • A. Kodimuthali Recent advances on phosphodiesterase 4 inhibitors for the treatment of asthma and chronic obstructive pulmonary disease J. Med. Chem. 51 2008 5471 5489
    • (2008) J. Med. Chem. , vol.51 , pp. 5471-5489
    • Kodimuthali, A.1
  • 20
    • 0024281428 scopus 로고
    • A novel form of TNF/cachectin is a cell surface cytotoxic transmembrane protein: Ramifications for the complex physiology of TNF
    • M. Kriegler A novel form of TNF/cachectin is a cell surface cytotoxic transmembrane protein: ramifications for the complex physiology of TNF Cell 53 1988 45 53
    • (1988) Cell , vol.53 , pp. 45-53
    • Kriegler, M.1
  • 23
    • 0033863530 scopus 로고    scopus 로고
    • Ongoing trials with matrix metalloproteinase inhibitors
    • P.D. Brown Ongoing trials with matrix metalloproteinase inhibitors Exp. Opin. Invest. Drugs 9 2000 2167 2177
    • (2000) Exp. Opin. Invest. Drugs , vol.9 , pp. 2167-2177
    • Brown, P.D.1
  • 24
    • 0033946952 scopus 로고    scopus 로고
    • Metalloproteinase inhibitors: New opportunities for the treatment of rheumatoid arthritis and osteoarthritis
    • T. Shaw Metalloproteinase inhibitors: new opportunities for the treatment of rheumatoid arthritis and osteoarthritis Exp. Opin. Invest. Drugs 9 2000 1469 1478 (Pubitemid 30433707)
    • (2000) Expert Opinion on Investigational Drugs , vol.9 , Issue.7 , pp. 1469-1478
    • Shaw, T.1    Nixon, J.S.2    Bottomley, K.M.3
  • 25
    • 0035056510 scopus 로고    scopus 로고
    • The clinical potential of matrix metalloproteinase inhibitors in the rheumatic disorders
    • S. Elliot, and T. Cawston The clinical potential of matrix metalloproteinase inhibitors in the rheumatic disorders Drugs Aging 18 2001 87 99 (Pubitemid 32269583)
    • (2001) Drugs and Aging , vol.18 , Issue.2 , pp. 87-99
    • Elliott, S.1    Cawston, T.2
  • 28
    • 0034775522 scopus 로고    scopus 로고
    • Biology of TACE inhibition
    • R.C. Newton Biology of TACE inhibition Ann. Rheum. Dis. 60 2001 25 32
    • (2001) Ann. Rheum. Dis. , vol.60 , pp. 25-32
    • Newton, R.C.1
  • 29
    • 0035341741 scopus 로고    scopus 로고
    • TACE and other ADAM proteases as targets for drug discovery
    • DOI 10.1016/S1359-6446(01)01738-X, PII S135964460101738X
    • M.L. Moss TACE and other ADAM proteases as targets for drug discovery Drug Discov. Today 6 2001 417 426 (Pubitemid 32328296)
    • (2001) Drug Discovery Today , vol.6 , Issue.8 , pp. 417-426
    • Moss, M.L.1    White, J.M.2    Lambert, M.H.3    Andrews, R.C.4
  • 38
    • 33645851018 scopus 로고    scopus 로고
    • Nitrogen-bridged substituted 8-arylquinolines as potent PDE IV inhibitors
    • P. Lacombe Nitrogen-bridged substituted 8-arylquinolines as potent PDE IV inhibitors Bioorg. Med. Chem. Lett. 16 2006 2608 2612
    • (2006) Bioorg. Med. Chem. Lett. , vol.16 , pp. 2608-2612
    • Lacombe, P.1
  • 42
    • 33645844249 scopus 로고    scopus 로고
    • Synthesis and structure-activity relationship of a novel, achiral series of TNF-α converting enzyme inhibitors
    • J.L. Gilmore Synthesis and structure-activity relationship of a novel, achiral series of TNF-α converting enzyme inhibitors Bioorg. Med. Chem. Lett. 16 2006 2699 2704
    • (2006) Bioorg. Med. Chem. Lett. , vol.16 , pp. 2699-2704
    • Gilmore, J.L.1
  • 43
    • 37549069911 scopus 로고    scopus 로고
    • Discovery of β-benzamido hydroxamic acids as potent, selective, and orally bioavailable TACE inhibitors
    • J.J.-W. Duan Discovery of β-benzamido hydroxamic acids as potent, selective, and orally bioavailable TACE inhibitors Bioorg. Med. Chem. Lett. 18 2008 241 246
    • (2008) Bioorg. Med. Chem. Lett. , vol.18 , pp. 241-246
    • Duan, J.J.-W.1
  • 44
    • 38149000234 scopus 로고    scopus 로고
    • α,β-Cyclic-β-benzamido hydroxamic acids: Novel templates for the design, synthesis, and evaluation of selective inhibitors of TNF-α converting enzyme (TACE)
    • G.R. Ott α,β-Cyclic-β-benzamido hydroxamic acids: novel templates for the design, synthesis, and evaluation of selective inhibitors of TNF-α converting enzyme (TACE) Bioorg. Med. Chem. Lett. 18 2008 694 699
    • (2008) Bioorg. Med. Chem. Lett. , vol.18 , pp. 694-699
    • Ott, G.R.1
  • 47
    • 53949085531 scopus 로고    scopus 로고
    • Discovery of novel hydroxamates as highly potent tumor necrosis factor-α converting enzyme inhibitors. Part II: Optimization of the S3′ pocket
    • R.D. Mazzola Jr. Discovery of novel hydroxamates as highly potent tumor necrosis factor-α converting enzyme inhibitors. Part II: Optimization of the S3′ pocket Bioorg. Med. Chem. Lett. 18 2008 5809 5814
    • (2008) Bioorg. Med. Chem. Lett. , vol.18 , pp. 5809-5814
    • Mazzola Jr., R.D.1
  • 48
    • 77951143988 scopus 로고    scopus 로고
    • Discovery of novel 6,6-heterocycles as transient receptor potential vanilloid (TRPV1) antagonists
    • C.A. Blum Discovery of novel 6,6-heterocycles as transient receptor potential vanilloid (TRPV1) antagonists J. Med. Chem. 53 2010 3330 3348
    • (2010) J. Med. Chem. , vol.53 , pp. 3330-3348
    • Blum, C.A.1
  • 49
    • 84858289520 scopus 로고    scopus 로고
    • CC bond formation at C-2 of a quinoline ring: Synthesis of 2-(1H-indol-3-yl) quinoline-3-carbonitrile derivatives as a new class of PDE4 inhibitors
    • K.S. Kumar CC bond formation at C-2 of a quinoline ring: synthesis of 2-(1H-indol-3-yl) quinoline-3-carbonitrile derivatives as a new class of PDE4 inhibitors Bioorg. Med. Chem. 20 2012 2199 2207
    • (2012) Bioorg. Med. Chem. , vol.20 , pp. 2199-2207
    • Kumar, K.S.1
  • 53
    • 84862779566 scopus 로고    scopus 로고
    • Discovery of oxazole-based PDE4 inhibitors with picomolar potency
    • R. Kuang Discovery of oxazole-based PDE4 inhibitors with picomolar potency Bioorg. Med. Chem. Lett. 22 2012 2594 2597
    • (2012) Bioorg. Med. Chem. Lett. , vol.22 , pp. 2594-2597
    • Kuang, R.1
  • 54
    • 75149177657 scopus 로고    scopus 로고
    • Design, synthesis and biological evaluation of new 2,3-diarylquinoline derivatives as selective cyclooxygenase-2 inhibitors
    • R. Ghodsi Design, synthesis and biological evaluation of new 2,3-diarylquinoline derivatives as selective cyclooxygenase-2 inhibitors Bioorg. Med. Chem. 18 2010 1029 1033
    • (2010) Bioorg. Med. Chem. , vol.18 , pp. 1029-1033
    • Ghodsi, R.1
  • 55
    • 79951726098 scopus 로고    scopus 로고
    • Chroman and tetrahydroquinoline ureas as potent TRPV1 antagonists
    • R.G. Schmidt Chroman and tetrahydroquinoline ureas as potent TRPV1 antagonists Bioorg. Med. Chem. Lett. 21 2011 1338 1341
    • (2011) Bioorg. Med. Chem. Lett. , vol.21 , pp. 1338-1341
    • Schmidt, R.G.1
  • 56
    • 84859805419 scopus 로고    scopus 로고
    • Discovery of novel 5,5-diarylpentadienamides as orally available transient receptor potential vanilloid 1 (TRPV1) antagonists
    • O. Saku Discovery of novel 5,5-diarylpentadienamides as orally available transient receptor potential vanilloid 1 (TRPV1) antagonists J. Med. Chem. 55 2012 3436 3451
    • (2012) J. Med. Chem. , vol.55 , pp. 3436-3451
    • Saku, O.1
  • 57
    • 60449108070 scopus 로고    scopus 로고
    • Quinolines as a novel structural class of potent and selective PDE4 inhibitors: Optimisation for oral administration
    • C.J. Lunniss Quinolines as a novel structural class of potent and selective PDE4 inhibitors: optimisation for oral administration Bioorg. Med. Chem. Lett. 19 2009 1380 1385
    • (2009) Bioorg. Med. Chem. Lett. , vol.19 , pp. 1380-1385
    • Lunniss, C.J.1
  • 58
    • 68349150615 scopus 로고    scopus 로고
    • Quinolines as a novel structural class of potent and selective PDE4 inhibitors. Optimisation for inhaled administration
    • M.D. Woodrow Quinolines as a novel structural class of potent and selective PDE4 inhibitors. Optimisation for inhaled administration Bioorg. Med. Chem. Lett. 19 2009 5261 5265
    • (2009) Bioorg. Med. Chem. Lett. , vol.19 , pp. 5261-5265
    • Woodrow, M.D.1
  • 59
    • 78349258913 scopus 로고    scopus 로고
    • Synthesis and pharmacological evaluation of some 4-oxoquinoline-2- carboxylic acid derivatives as anti-inflammatory and analgesic agents
    • O. Mazzoni Synthesis and pharmacological evaluation of some 4-oxoquinoline-2-carboxylic acid derivatives as anti-inflammatory and analgesic agents Arch. Pharm. Chem. Life Sci. 10 2010 561 569
    • (2010) Arch. Pharm. Chem. Life Sci. , vol.10 , pp. 561-569
    • Mazzoni, O.1
  • 60
    • 20944441781 scopus 로고    scopus 로고
    • Prostaglandin-mediated control of rat brain kynurenic acid synthesis - Opposite actions by COX-1 and COX-2 isoforms
    • DOI 10.1007/s00702-004-0231-y
    • L. Schwieler Prostaglandin-mediated control of rat brain kynurenic acid synthesis-opposite actions by COX-1 and COX-2 isoforms J. Neural Transm. 112 2005 863 872 (Pubitemid 40869075)
    • (2005) Journal of Neural Transmission , vol.112 , Issue.7 , pp. 863-872
    • Schwieler, L.1    Erhardt, S.2    Erhardt, C.3    Engberg, G.4
  • 61
    • 80054788578 scopus 로고    scopus 로고
    • Novel 1-alkynyl substituted 1,2-dihydroquinoline derivatives from nimesulide (and their 2-oxo analogues): A new strategy to identify inhibitors of PDE4B
    • S. Pal Novel 1-alkynyl substituted 1,2-dihydroquinoline derivatives from nimesulide (and their 2-oxo analogues): a new strategy to identify inhibitors of PDE4B Bioorg. Med. Chem. Lett. 21 2011 6573 6576
    • (2011) Bioorg. Med. Chem. Lett. , vol.21 , pp. 6573-6576
    • Pal, S.1
  • 64
    • 67650083504 scopus 로고    scopus 로고
    • Synthesis and biological evaluation of new 4-carboxyl quinoline derivatives as cyclooxygenase-2 inhibitors
    • A. Zarghi Synthesis and biological evaluation of new 4-carboxyl quinoline derivatives as cyclooxygenase-2 inhibitors Bioorg. Med. Chem. 17 2009 5312 5317
    • (2009) Bioorg. Med. Chem. , vol.17 , pp. 5312-5317
    • Zarghi, A.1
  • 65
    • 0346059512 scopus 로고    scopus 로고
    • Synthesis and anti-inflammatory evaluation of 4-anilinofuro[2,3-b] quinoline and 4-phenoxyfuro[2,3-b]quinoline derivatives. Part 3
    • DOI 10.1016/j.bmc.2003.10.051
    • Y.-L. Chen Synthesis and anti-inflammatory evaluation of 4-anilinofuro[2,3-b]quinoline and 4-phenoxyfuro[2,3-b]quinoline derivatives. Part 3 Bioorg. Med. Chem. 12 2004 387 392 (Pubitemid 38064210)
    • (2004) Bioorganic and Medicinal Chemistry , vol.12 , Issue.2 , pp. 387-392
    • Chen, Y.-L.1    Chen, I.-L.2    Lu, C.-M.3    Tzeng, C.-C.4    Tsao, L.-T.5    Wang, J.-P.6
  • 67
    • 46449106774 scopus 로고    scopus 로고
    • Synthesis and anti-inflammatory activity evaluation of novel 7-alkoxy-1-amino-4,5-dihydro[1,2,4]triazole[4,3-a]quinolines
    • X.-Y. Sun Synthesis and anti-inflammatory activity evaluation of novel 7-alkoxy-1-amino-4,5-dihydro[1,2,4]triazole[4,3-a]quinolines Arch. Pharm. Chem. Life Sci. 341 2008 288 293
    • (2008) Arch. Pharm. Chem. Life Sci. , vol.341 , pp. 288-293
    • Sun, X.-Y.1
  • 69
    • 53949104202 scopus 로고    scopus 로고
    • Synthesis and anti-inflammatory structure-activity relationships of thiazine-quinoline-quinones: Inhibitors of the neutrophil respiratory burst in a model of acute gouty arthritis
    • E.W. Chia Synthesis and anti-inflammatory structure-activity relationships of thiazine-quinoline-quinones: inhibitors of the neutrophil respiratory burst in a model of acute gouty arthritis Bioorg. Med. Chem. 16 2008 9432 9442
    • (2008) Bioorg. Med. Chem. , vol.16 , pp. 9432-9442
    • Chia, E.W.1
  • 70
    • 40949138241 scopus 로고    scopus 로고
    • Synthesis, analgesic, anti-inflammatory, and antimicrobial activity of some novel pyrimido[4,5-b]quinolin-4-ones
    • A.B.A. El-Gazzar Synthesis, analgesic, anti-inflammatory, and antimicrobial activity of some novel pyrimido[4,5-b]quinolin-4-ones Bioorg. Med. Chem. 16 2008 3261 3273
    • (2008) Bioorg. Med. Chem. , vol.16 , pp. 3261-3273
    • El-Gazzar, A.B.A.1
  • 71
    • 61449168879 scopus 로고    scopus 로고
    • New acyclic nucleosides analogues as potential analgesic, anti-inflammatory, anti-oxidant and anti-microbial derived from pyrimido[4,5-b]quinolines
    • A.B.A. El-Gazzar New acyclic nucleosides analogues as potential analgesic, anti-inflammatory, anti-oxidant and anti-microbial derived from pyrimido[4,5-b]quinolines Eur. J. Med. Chem. 44 2009 1427 1436
    • (2009) Eur. J. Med. Chem. , vol.44 , pp. 1427-1436
    • El-Gazzar, A.B.A.1
  • 73
    • 44849120587 scopus 로고    scopus 로고
    • Drug Insight: Tumor necrosis factor-converting enzyme as a pharmaceutical target for rheumatoid arthritis
    • DOI 10.1038/ncprheum0797, PII NCPRHEUM0797
    • M.L. Moss Drug insight: tumor necrosis factor-converting enzyme as a pharmaceutical target for rheumatoid arthritis Nat. Clin. Pract. Rheumatol. 4 2008 300 309 (Pubitemid 351791441)
    • (2008) Nature Clinical Practice Rheumatology , vol.4 , Issue.6 , pp. 300-309
    • Moss, M.L.1    Sklair-Tavron, L.2    Nudelman, R.3


* 이 정보는 Elsevier사의 SCOPUS DB에서 KISTI가 분석하여 추출한 것입니다.